FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2609431074> ?p ?o ?g. }

• W2609431074 endingPage "12" @default.
• W2609431074 startingPage "11" @default.
• W2609431074 abstract "INTRODUCTION: Several experimental studies suggest that growth hormone-based therapies have the potential to accelerate and augment axonal regeneration while simultaneously act directly on muscle and Schwann cells (SCs) to minimize denervation atrophy prior to re-innervation. The purpose of this study was to assess the impact of growth hormone (GH) therapy on preventing the deleterious effects of chronic denervation (CD) injury on nerve regeneration and resulting muscle function. We hypothesized that systemic GH therapy can maintain chronically-denervated muscle and SCs, accelerate axonal regeneration, and improve murine extremity function in the setting of chronic denervation (CD) by preserving muscle mass and promoting motor reinnervation. METHODS: We utilized a newly-developed, rat forelimb CD model to assess the effects of GH therapy on: a) improving nerve regeneration; and b) preventing muscle atrophy and augmenting muscle re-innervation and function. Four groups of rats were examined: (1) Group-1 (n = 8) underwent 8 weeks of median nerve CD injury followed by repair; (2) Group-2 (experimental, n = 8) underwent 8 weeks of median nerve CD followed by repair and treatment with highly purified lyophilized pituitary porcine GH (0.6 mg/day); (3) Group-3 animals (n = 8) underwent no median nerve CD injury; (4) Group-4 animals (n = 8) were naïve controls. All animals underwent weekly muscle functional testing followed by median nerve and flexor muscle harvest for nerve histomorphometry, muscle weight, atrophy, and re-innervation analysis. To enable the assessment of the effects of GH therapy on maintaining denervated muscle and SCs: Group-1 animals also underwent 8 weeks of contralateral sciatic nerve CD; Group-2 animals underwent 8 weeks of sciatic nerve CD (w/ GH treatment as stated above); Group-3 animals underwent 1 week of sciatic nerve CD; and Group-4 animals underwent no sciatic nerve CD. The sciatic nerve and lateral gastrocnemius muscle were harvested after completion of sciatic nerve CD injury time point to assess for SC proliferation/senescence markers (via qPCR) and muscle atrophy (via muscle weight and cross-sectional area muscle staining). RESULTS: Median nerve regeneration was higher in GH-treated animals when compared to untreated controls as measured by axon density (p < 0.005), axon diameter (p < 0.0001), and myelin thickness (p < 0.0001). Furthermore, GH improved muscle re-innervation (27.9% vs 38.0% NMJs re-innervated; p < 0.02) and prevented muscle atrophy (865 ± 48.3 vs 1081 ± 101.4 μM2; p < 0.02). GH-treated rats demonstrated greater functional muscle recovery as compared to untreated controls (hand grip: 1.8 ± 0.3 N vs. 1.0 ± 0.1 N, p=0.001). Lastly, Group 2 animals demonstrated higher expression of SC proliferation and migration markers, c-Jun & erbB-3, and less muscle atrophy (0.21 ± 0.02 g vs. 0.17 ± 0.01 g; P=0.55) when compared to Group 1 at 8 weeks after sciatic nerve CD. CONCLUSION: Systemic GH therapy can improve nerve regeneration and maintain chronically-denervated muscle by promoting re-innervation and subsequent muscle function." @default.
• W2609431074 created "2017-05-05" @default.
• W2609431074 creator A5029247116 @default.
• W2609431074 creator A5032170193 @default.
• W2609431074 creator A5041171722 @default.
• W2609431074 creator A5051886924 @default.
• W2609431074 creator A5054875310 @default.
• W2609431074 creator A5060794789 @default.
• W2609431074 creator A5066248105 @default.
• W2609431074 creator A5074805124 @default.
• W2609431074 creator A5075107467 @default.
• W2609431074 creator A5076070650 @default.
• W2609431074 creator A5089703293 @default.
• W2609431074 date "2017-04-01" @default.
• W2609431074 modified "2023-10-06" @default.
• W2609431074 title "Abstract 15" @default.
• W2609431074 doi "https://doi.org/10.1097/01.gox.0000516536.27383.ac" @default.
• W2609431074 hasPublicationYear "2017" @default.
• W2609431074 type Work @default.
• W2609431074 sameAs 2609431074 @default.
• W2609431074 citedByCount "0" @default.
• W2609431074 crossrefType "journal-article" @default.
• W2609431074 hasAuthorship W2609431074A5029247116 @default.
• W2609431074 hasAuthorship W2609431074A5032170193 @default.
• W2609431074 hasAuthorship W2609431074A5041171722 @default.
• W2609431074 hasAuthorship W2609431074A5051886924 @default.
• W2609431074 hasAuthorship W2609431074A5054875310 @default.
• W2609431074 hasAuthorship W2609431074A5060794789 @default.
• W2609431074 hasAuthorship W2609431074A5066248105 @default.
• W2609431074 hasAuthorship W2609431074A5074805124 @default.
• W2609431074 hasAuthorship W2609431074A5075107467 @default.
• W2609431074 hasAuthorship W2609431074A5076070650 @default.
• W2609431074 hasAuthorship W2609431074A5089703293 @default.
• W2609431074 hasBestOaLocation W26094310741 @default.
• W2609431074 hasConcept C126322002 @default.
• W2609431074 hasConcept C126894567 @default.
• W2609431074 hasConcept C134018914 @default.
• W2609431074 hasConcept C141071460 @default.
• W2609431074 hasConcept C171056886 @default.
• W2609431074 hasConcept C2775991916 @default.
• W2609431074 hasConcept C2776263037 @default.
• W2609431074 hasConcept C2776805190 @default.
• W2609431074 hasConcept C2779649809 @default.
• W2609431074 hasConcept C2781172350 @default.
• W2609431074 hasConcept C71924100 @default.
• W2609431074 hasConcept C86803240 @default.
• W2609431074 hasConcept C95444343 @default.
• W2609431074 hasConceptScore W2609431074C126322002 @default.
• W2609431074 hasConceptScore W2609431074C126894567 @default.
• W2609431074 hasConceptScore W2609431074C134018914 @default.
• W2609431074 hasConceptScore W2609431074C141071460 @default.
• W2609431074 hasConceptScore W2609431074C171056886 @default.
• W2609431074 hasConceptScore W2609431074C2775991916 @default.
• W2609431074 hasConceptScore W2609431074C2776263037 @default.
• W2609431074 hasConceptScore W2609431074C2776805190 @default.
• W2609431074 hasConceptScore W2609431074C2779649809 @default.
• W2609431074 hasConceptScore W2609431074C2781172350 @default.
• W2609431074 hasConceptScore W2609431074C71924100 @default.
• W2609431074 hasConceptScore W2609431074C86803240 @default.
• W2609431074 hasConceptScore W2609431074C95444343 @default.
• W2609431074 hasIssue "4S" @default.
• W2609431074 hasLocation W26094310741 @default.
• W2609431074 hasLocation W26094310742 @default.
• W2609431074 hasOpenAccess W2609431074 @default.
• W2609431074 hasPrimaryLocation W26094310741 @default.
• W2609431074 hasRelatedWork W1906233383 @default.
• W2609431074 hasRelatedWork W2039149021 @default.
• W2609431074 hasRelatedWork W2084195233 @default.
• W2609431074 hasRelatedWork W2314606094 @default.
• W2609431074 hasRelatedWork W2369300776 @default.
• W2609431074 hasRelatedWork W2400796805 @default.
• W2609431074 hasRelatedWork W2609431074 @default.
• W2609431074 hasRelatedWork W3131388293 @default.
• W2609431074 hasRelatedWork W3208316966 @default.
• W2609431074 hasRelatedWork W41240475 @default.
• W2609431074 hasVolume "5" @default.
• W2609431074 isParatext "false" @default.
• W2609431074 isRetracted "false" @default.
• W2609431074 magId "2609431074" @default.
• W2609431074 workType "article" @default.